Triethylamine → tert-Butyl 4-{4-[methoxy(methyl)carbamoyl]-1,3-thiazol-2-yl}piperidine-1-carboxylate
反応式
C(N(CC)CC)C.[C:8]([O:12][C:13]([N:15]1[CH2:20][CH2:19][CH:18]([C:21]2[S:22][CH:23]=[C:24]([C:26]([OH:28])=O)[N:25]=2)[CH2:17][CH2:16]1)=[O:14])([CH3:11])([CH3:10])[CH3:9].[Cl-].[CH3:30][O:31][NH2+:32][CH3:33].Cl.C(N=C=NCCCN(C)C)C>ClCCl.CN(C)C1C=CN=CC=1.O>[CH3:30][O:31][N:32]([CH3:33])[C:26]([C:24]1[N:25]=[C:21]([CH:18]2[CH2:17][CH2:16][N:15]([C:13]([O:12][C:8]([CH3:11])([CH3:10])[CH3:9])=[O:14])[CH2:20][CH2:19]2)[S:22][CH:23]=1)=[O:28]参加物
反応物 4
生成物 1
試薬・触媒・溶媒 3
実験手順
At room temperature, triethylamine (324 mg) was added to a suspension of 2-[1-(tert-butoxycarbonyl)piperidin-4-yl]-1,3-thiazole-4-carboxylic acid (1.0 g) in dichloromethane (30 mL). After ten minutes of stirring, methoxy(methyl)ammonium chloride (312 mg), 4-dimethylaminopyridine (39 mg) and 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide HCl salt (675 mg) were added. The mixture was stirred at room temperature overnight, and water was then added. The aqueous phase was separated off and extracted with ethyl acetate. The combined organic phases are dried over sodium sulphate and concentrated under reduced pressure. The residue was purified chromatographically. This gave tert-butyl 4-{4-[methoxy(methyl)carbamoyl]-1,3-thiazol-2-yl}piperidine-1-carboxylate (1.0 g).
後処理
- stirringThe mixture was stirred at room temperature overnight
- customThe aqueous phase was separated off
- extractionextracted with ethyl acetate
- dry with materialThe combined organic phases are dried over sodium sulphate
- concentrationconcentrated under reduced pressure
- customThe residue was purified chromatographically
出典と根拠
- ORDレコード
- ord-f281a30edde24716bd2b286273c1e54d
- 出典データセット
- uspto-grants-2015_12
- 特許番号
- US09220266B2
反応ノート
読み込み中…